Potentiation of botulinum toxin type A with oral anti-spasticity medications in the management of focal spasticity.
Dai
Alper
A
D000284:Administration, Oral; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage*; D002547:Cerebral Palsy / Q000188:drug therapy*; D004357:Drug Synergism; D006801:Humans; D007273:Injections, Intramuscular; D009125:Muscle Relaxants, Central / Q000008:administration & dosage*; D009128:Muscle Spasticity / Q000188:drug therapy*; D009465:Neuromuscular Agents / Q000008:administration & dosage*
D009125:Muscle Relaxants, Central; D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A